CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CVS Health (CVS) PT Raised to $91 at RBC Capital; Technical Issues Weighing on Shares
May 3, 2018 8:39 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $91.00 (from $89.00) while maintaining a Outperform rating.
Analyst George Hill commented, "CVS reported Q1 results that beat our estimates and consensus, driven by stronger- than-expected results in the Pharmacy/LTC... More
